1. Home
  2. GPCR vs KW Comparison

GPCR vs KW Comparison

Compare GPCR & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • KW
  • Stock Information
  • Founded
  • GPCR 2016
  • KW 1977
  • Country
  • GPCR United States
  • KW United States
  • Employees
  • GPCR N/A
  • KW N/A
  • Industry
  • GPCR
  • KW Real Estate
  • Sector
  • GPCR
  • KW Finance
  • Exchange
  • GPCR Nasdaq
  • KW Nasdaq
  • Market Cap
  • GPCR 1.1B
  • KW 940.4M
  • IPO Year
  • GPCR 2023
  • KW 1992
  • Fundamental
  • Price
  • GPCR $19.01
  • KW $7.58
  • Analyst Decision
  • GPCR Strong Buy
  • KW Hold
  • Analyst Count
  • GPCR 7
  • KW 1
  • Target Price
  • GPCR $76.17
  • KW $13.00
  • AVG Volume (30 Days)
  • GPCR 684.5K
  • KW 1.2M
  • Earning Date
  • GPCR 08-07-2025
  • KW 08-06-2025
  • Dividend Yield
  • GPCR N/A
  • KW 6.18%
  • EPS Growth
  • GPCR N/A
  • KW N/A
  • EPS
  • GPCR N/A
  • KW N/A
  • Revenue
  • GPCR N/A
  • KW $514,600,000.00
  • Revenue This Year
  • GPCR N/A
  • KW $31.15
  • Revenue Next Year
  • GPCR N/A
  • KW $2.98
  • P/E Ratio
  • GPCR N/A
  • KW N/A
  • Revenue Growth
  • GPCR N/A
  • KW N/A
  • 52 Week Low
  • GPCR $13.22
  • KW $5.98
  • 52 Week High
  • GPCR $47.48
  • KW $11.88
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 33.96
  • KW 66.92
  • Support Level
  • GPCR $18.50
  • KW $7.16
  • Resistance Level
  • GPCR $19.40
  • KW $7.83
  • Average True Range (ATR)
  • GPCR 1.18
  • KW 0.24
  • MACD
  • GPCR -0.17
  • KW 0.08
  • Stochastic Oscillator
  • GPCR 9.86
  • KW 79.10

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: